Getting the Most Out of Systematic Literature Reviews With DistillerSR
Chris Waters-Banker, Research Lead for Medlior Health Outcomes Research Ltd., outlines five ways to utilize the filter feature to optimize [...]
Association for Accessible Medicines (AAM) Names Health Care Advocate Dan Leonard President and CEO
Dan Leonard was appointed President and Chief Executive Officer of The Association for Accessible Medicines (AAM) today by the association’s [...]
Aris Angelis and Colleagues Evaluate the Institute for Clinical and Economic Review’s (ICER) 2020 Value Framework Update
Angelis et al. use using multiple criteria decision analysis and decision conferencing to evaluate ICER’s updated value framework. The authors [...]
The Professional Society for Health Economics and Outcomes Research (ISPOR) Announces New COVID-19 Member Community
ISPOR launched its COVID-19 Member Community, a platform where ISPOR members can share ideas, discuss challenges, and post questions related [...]
Medical Device Innovation Consortium’s (MDIC) Real-World Evidence Framework for In Vitro Diagnostics Takes Aim at COVID-19
The Medical Device Innovation Consortium (MDIC) finished developing its Real-World Evidence (RWE) Framework for regulatory decision-making for in vitro diagnostics [...]
The European Medicines Agency (EMA) Seeks to Develop Sentinel-Style RWD Database
The European Medicines Agency is soliciting input from organizations interested in developing, operating, and maintaining a healthcare data analysis platform [...]
How is the Institute for Clinical and Economic Review (ICER) Incorporating the Patient’s Voice in Value Assessments?
Evaluating the cost-effectiveness of interventions with value assessment frameworks continues to gain traction in US healthcare. Now attention is shifting [...]
New Research Agenda Seeks to Usher in New Era of Patient-centered Personalized Medicine.
The Personalized Medicine Coalition (PMC) released a new patient-centered research agenda for personalized medicine defining 45 research questions across nine [...]
Employers, Insurers Unnerved by Rising Virtual Doctor Visit Rates
Employers fear higher rates for telehealth will eliminate savings. However, a shift in provider reimbursement may ultimately help lower costs [...]
How is Real-World Data Leveraged to Improve Outcomes in the Context of COVID-19?
In this time of crisis brought on by the COVID-19 pandemic, researchers and leaders have to look beyond time-intensive, expensive [...]
Study Finds Cost-sharing Assistance Programs Can Save Patients Thousands While Leading to Improved Adherence and Health Outcomes.
According to a recent analysis by IQVIA, chronically ill patients using cost-sharing assistance saved hundreds to thousands of dollars on [...]
How Can Excessive Price Increases Be Better Regulated?
Much of the overall spending on prescription drugs in the United States can be attributed to price increases, resulting in [...]
What is the Most Effective Way to Navigate Pricing Models for COVID-19 Innovations?
Preliminary clinical benefit information is translated into longer-term health benefit and economic value through pricing models, making them invaluable for [...]
Value of a QALY for France
Until now, no cost-effectiveness threshold (CET) has been officially proposed in France to qualify incremental cost-effectiveness ratios (ICERs). To address [...]
How Did Pharmaceutical Policy Reform Change the Healthcare Landscape in China?
China’s pharmaceutical market is second only to the United States valued at $137 billion (USD). Fueling Growth has been fueled [...]
Aetna and Cleveland Clinic Launch Co-branded Health Plan.
The joint Aetna Whole Health – Cleveland Clinic plan, available in NE Ohio, utilizes Cleveland Clinic's providers to provide a [...]
[Presentation] IMPACCT: Real World Evidence–Use of Real World Data Outside of Traditional Comparative Effectiveness Research
[Presentation] IMPACCT: Real World Evidence--Use of Real World Data Outside of Traditional Comparative Effectiveness Research by Ravi Iyer, Director GHEOR, [...]
[Presentation] IMPACCT: Real World Evidence–The Rile of Real World Evidence (RWE) in a Comprehensive Product Evidence Generation Plan
[Presentation] IMPACCT: Real World Evidence--The Rile of Real World Evidence (RWE) in a Comprehensive Product Evidence Generation Plan by Cathy [...]
[Presentation] IMPACCT: Real World Evidence–Lessons Learned From The Development And Implementation of an Integrated Data And Evidence Strategy
IMPACCT: Real World Evidence--Lessons Learned From The Development And Implementation of an Integrated Data And Evidence Strategy by Tony Hebden [...]
Cost-Sharing Waivers for COVID-19 Treatment Are Expiring
Cost-sharing waivers for COVID-19 treatment are due to expire in the upcoming months. Approximately 88% in individual and fully insured [...]
[Webinar] Value Assessment in the Age of COVID-19: Meeting the Challenges
An important discussion is developing around Value Assessment (VA) and Health Technology Assessment (HTA) as COVID-19 intensifies challenges to effectively [...]
Teva Pharmaceuticals Stock Plunges 15.4%
Teva Pharmaceutical stands accused of defrauding Medicare using a kickback scheme to boost sales of Copaxone, prompting the US government [...]
[Video Chat] A Pandemic Means Society Needs Information Fast. Can Researchers Provide It?
Don't miss Stat's upcoming video chat on Thursday, Sept. 17 at 1 p.m. ET / 10 a.m. PT: Getting real [...]
[PODCAST] Open Access: Opportunities and Challenges
As the principles of open science become more widely adopted, open access publishing is an increasingly debated topic. Join International [...]
Payer Contact in a “Contactless” World: Achieving Early Engagement
The COVID-19 pandemic has prompted life sciences organizations to quickly pivot their payer strategic approach and tactical implementation. Engaging payers [...]